12/12/25 20:30 | 12/11/25 | AARD | Health | Drug | Pharmaceutical Preparations | Sun Nelson | CA | O | CFO | P | 43 | 14.40 | 0 | 3 | 3 | 108 | D | | | | | | | | | | | | | | |
12/12/25 20:30 | 12/11/25 | AARD | Health | Drug | Pharmaceutical Preparations | Lee Tien-Li | CA | DOT | CEO | P | 101 | 14.49 | 0 | 7 | 0 | 3,026 | D | | | | | | | | | | | | | | |
10/16/25 18:14 | 10/15/25 | AARD | Health | Drug | Pharmaceutical Preparations | Lee Tien-Li | CA | DOT | CEO | M.d | 5 | 4.24 | 0 | 1 | 0 | 3,019 | D | | | | | | | | | | | | | | |
10/16/25 18:12 | 10/15/25 | AARD | Health | Drug | Pharmaceutical Preparations | Jones Bryan | CA | O | COO | M.d | 5 | 4.24 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
9/16/25 06:15 | 9/15/25 | AARD | Health | Drug | Pharmaceutical Preparations | Lee Tien-Li | CA | DOT | CEO | P | 97 | 9.66 | 0 | 10 | 0 | 3,017 | D | | | | | | | | | | | | | | |
9/12/25 20:28 | 9/10/25 | AARD | Health | Drug | Pharmaceutical Preparations | Lee Tien-Li | CA | DOT | CEO | P.m | 161 | 8.03 | 0 | 20 | 1 | 3,007 | D | | | | | | | | | | | | | | |
9/10/25 17:36 | 9/9/25 | AARD | Health | Drug | Pharmaceutical Preparations | Sun Nelson | CA | O | CFO | P | 48 | 8.07 | 0 | 6 | 6 | 105 | D | | | | | | | | | | | | | | |
8/29/25 16:05 | 8/28/25 | AARD | Health | Drug | Pharmaceutical Preparations | Lee Tien-Li | CA | DOT | CEO | M.d | 73 | 4.24 | 0 | 17 | 1 | 2,987 | D | | | | | | | | | | | | | | |
2/19/25 17:44 | 2/14/25 | AARD | Health | Drug | Pharmaceutical Preparations | Decheng Capital Global Life Sciences Fund Iv, L.P. | E9 | T | | P.d | 20,000 | 16.00 | 0 | 1,250 | 47 | 3,917 | I | | | | | | | | | | | | | | |
2/19/25 16:35 | 2/14/25 | AARD | Health | Drug | Pharmaceutical Preparations | Lee Tien-Li | CA | DOT | CEO | P.d | 265 | 16.00 | 0 | 17 | 1 | 2,970 | D | | | | | | | | | | | | | | |
2/19/25 16:30 | 2/14/25 | AARD | Health | Drug | Pharmaceutical Preparations | Sun Nelson | CA | O | CFO | P.d | 160 | 16.00 | 0 | 10 | 11 | 99 | D | | | | | | | | | | | | | | |
2/19/25 16:02 | 2/14/25 | AARD | Health | Drug | Pharmaceutical Preparations | Cormorant Asset Management, LP | MA | H | Former 1 | P.d | 3,000 | 16.00 | 0 | 188 | 23 | 988 | I | | | | | | | | | | | | | | |